title: [The patient under antidepressive and antipsychotic therapy].
abstract: The family physician is responsible for the primary medical care of a mentally ill person. Because these patients are frequently treated with antidepressants or antipsychotic drugs, the family physician should be well-informed of the indication, dosage and side effects of these substances. Among antidepressants, selective serotonin reuptake inhibitors (SSRI) and newer substances usually have a more favorable side effect profile than tricyclic antidepressants (TCA). Atypical antipsychotic drugs show a lower risk for extrapyramidal motor disorders in contrast to conventional antipsychotic drugs. Undesired effects such as weight gain can, however, occur in all substance groups. The treatment of somatic comorbidities in these mentally ill patients and, likewise, the prophylaxis to prevent recurrence of depressive and schizophrenic diseases are also the responsibility of the family physician.
authors.affiliation: Zentralinstitut für Seelische Gesundheit, Klinik für Psychiatrie und Psychotherapie, Mannheim.
authors.forename: Jana
authors.initials: J
authors.lastname: Hummel
authors.forename: Florian
authors.initials: F
authors.lastname: Lederbogen
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D005194:Family Practice; D006801:Humans; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D017367:Selective Serotonin Reuptake Inhibitors